BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27444647)

  • 1. Structural and dynamic insights into the subtype-specific IP3-binding mechanism of the IP3 receptor.
    Lee SY; Yoo HS; Choi HS; Chung KY; Seo MD
    Biochem J; 2016 Oct; 473(20):3533-3543. PubMed ID: 27444647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of inositol 1,4,5-trisphosphate binding to the various inositol 1,4,5-trisphosphate receptor isoforms by thimerosal and cyclic ADP-ribose.
    Vanlingen S; Sipma H; De Smet P; Callewaert G; Missiaen L; De Smedt H; Parys JB
    Biochem Pharmacol; 2001 Apr; 61(7):803-9. PubMed ID: 11274965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IP3 receptor/Ca2+ channel and its cellular function.
    Mikoshiba K
    Biochem Soc Symp; 2007; (74):9-22. PubMed ID: 17233576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Ca2+ in triggering inositol 1,4,5-trisphosphate receptor ubiquitination.
    Alzayady KJ; Wojcikiewicz RJ
    Biochem J; 2005 Dec; 392(Pt 3):601-6. PubMed ID: 16134970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
    Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor.
    Saleem H; Tovey SC; Molinski TF; Taylor CW
    Br J Pharmacol; 2014 Jul; 171(13):3298-312. PubMed ID: 24628114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative order of IP3 sensitivity of types 1 and 3 IP3 receptors is pH dependent.
    De Smet P; Parys JB; Vanlingen S; Bultynck G; Callewaert G; Galione A; De Smedt H; Missiaen L
    Pflugers Arch; 1999 Jul; 438(2):154-8. PubMed ID: 10370101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol 1,4,5-trisphosphate activates TRPC3 channels to cause extracellular Ca2+ influx in airway smooth muscle cells.
    Song T; Hao Q; Zheng YM; Liu QH; Wang YX
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1455-66. PubMed ID: 26453517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction.
    Bultynck G; Szlufcik K; Kasri NN; Assefa Z; Callewaert G; Missiaen L; Parys JB; De Smedt H
    Biochem J; 2004 Jul; 381(Pt 1):87-96. PubMed ID: 15015936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 80K-H interacts with inositol 1,4,5-trisphosphate (IP3) receptors and regulates IP3-induced calcium release activity.
    Kawaai K; Hisatsune C; Kuroda Y; Mizutani A; Tashiro T; Mikoshiba K
    J Biol Chem; 2009 Jan; 284(1):372-380. PubMed ID: 18990696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species.
    Bánsághi S; Golenár T; Madesh M; Csordás G; RamachandraRao S; Sharma K; Yule DI; Joseph SK; Hajnóczky G
    J Biol Chem; 2014 Mar; 289(12):8170-81. PubMed ID: 24469450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-Induced Ca
    Kochkina EN; Kopylova EE; Rogachevskaja OA; Kovalenko NP; Kabanova NV; Kotova PD; Bystrova MF; Kolesnikov SS
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant IP
    Ando H; Hirose M; Mikoshiba K
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12259-12264. PubMed ID: 30429331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological consequences of isoform-specific IP
    Kerkhofs M; Seitaj B; Ivanova H; Monaco G; Bultynck G; Parys JB
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1707-1717. PubMed ID: 29906486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol (1,4,5)-Trisphosphate Receptors in Invasive Breast Cancer: A New Prognostic Tool?
    Foulon A; Rybarczyk P; Jonckheere N; Brabencova E; Sevestre H; Ouadid-Ahidouch H; Rodat-Despoix L
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for activation and gating of IP
    Schmitz EA; Takahashi H; Karakas E
    Nat Commun; 2022 Mar; 13(1):1408. PubMed ID: 35301323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand sensitivity of type-1 inositol 1,4,5-trisphosphate receptor is enhanced by the D2594K mutation.
    Tambeaux A; Aguilar-Sánchez Y; Santiago DJ; Mascitti M; DiNovo KM; Mejía-Alvarez R; Fill M; Wayne Chen SR; Ramos-Franco J
    Pflugers Arch; 2023 May; 475(5):569-581. PubMed ID: 36881190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gating dynamics of different IP
    Cai X; Li X; Qi H; Wei F; Chen J; Shuai J
    Phys Biol; 2016 Oct; 13(5):056005. PubMed ID: 27749281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.
    Schulman JJ; Wright FA; Kaufmann T; Wojcikiewicz RJH
    J Biol Chem; 2013 Aug; 288(35):25340-25349. PubMed ID: 23884412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of inositol 1,4,5-trisphosphate (IP
    Chandran A; Chee X; Prole DL; Rahman T
    Sci Rep; 2019 Feb; 9(1):2454. PubMed ID: 30792485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.